Covid-19 and Parkinson's disease: an overview
- PMID: 34313818
- PMCID: PMC8313415
- DOI: 10.1007/s00415-021-10721-4
Covid-19 and Parkinson's disease: an overview
Abstract
In March 2020, WHO declared Covid-19 outbreak pandemic. There has been increasing evidence that frail, old, multi-pathological patients are at greater risk of developing severe Covid-19 infection than younger, healthy ones. Covid-19's impact on Parkinson's Disease (PD) patients could be analysed through both the influence on PD patients' health and their risk of developing severe Covid-19, and the consequences of lockdown and restrictive measures on mental and cognitive health on both patients and caregivers. Moreover, there are critical issues to be considered about patients' care and management through an unprecedented time like this. One important issue to consider is physiotherapy, as most patients cannot keep exercising because of restrictive measures which has profoundly impacted on their health. Lastly, the relationship between PD and Sars-Cov2 may be even more complicated than it seems as some studies have hypothesized a possible Covid-19-induced parkinsonism. Hereby, we review the state of the art about the relationship between Covid-19 and Parkinson's Disease, focusing on each of these five points.
Keywords: Covid-19; Movement disorders; Parkinson’s disease.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The Authors have no disclosure to declare.
Similar articles
-
The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.PLoS One. 2021 May 6;16(5):e0251313. doi: 10.1371/journal.pone.0251313. eCollection 2021. PLoS One. 2021. PMID: 33956891 Free PMC article.
-
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy.Neurol Sci. 2020 Jun;41(6):1373-1375. doi: 10.1007/s10072-020-04442-1. Epub 2020 May 3. Neurol Sci. 2020. PMID: 32363506 Free PMC article.
-
[Risk and course of COVID-19 in patients with Parkinson's disease].Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(9):152-156. doi: 10.17116/jnevro2021121091152. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34693704 Russian.
-
Viruses, parkinsonism and Parkinson's disease: the past, present and future.J Neural Transm (Vienna). 2022 Sep;129(9):1119-1132. doi: 10.1007/s00702-022-02536-y. Epub 2022 Aug 29. J Neural Transm (Vienna). 2022. PMID: 36036863 Free PMC article. Review.
-
Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease.CNS Neurol Disord Drug Targets. 2022;21(3):235-245. doi: 10.2174/1871527320666210820092817. CNS Neurol Disord Drug Targets. 2022. PMID: 34414876 Review.
Cited by
-
Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis.Front Immunol. 2024 Jul 3;15:1390149. doi: 10.3389/fimmu.2024.1390149. eCollection 2024. Front Immunol. 2024. PMID: 39021576 Free PMC article.
-
Effects and parameters of community-based exercise on motor symptoms in Parkinson's disease: a meta-analysis.BMC Neurol. 2022 Dec 29;22(1):505. doi: 10.1186/s12883-022-03027-z. BMC Neurol. 2022. PMID: 36581847 Free PMC article.
-
No genetic link between Parkinson's disease and SARS-CoV-2 infection: a two-sample Mendelian randomization study.Front Neurol. 2024 Jun 28;15:1393888. doi: 10.3389/fneur.2024.1393888. eCollection 2024. Front Neurol. 2024. PMID: 39006236 Free PMC article.
-
COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.Neurol Res Pract. 2022 Jul 11;4(1):27. doi: 10.1186/s42466-022-00192-x. Neurol Res Pract. 2022. PMID: 35811323 Free PMC article.
-
Exercise for frailty research frontiers: a bibliometric analysis and systematic review.Front Med (Lausanne). 2024 May 1;11:1341336. doi: 10.3389/fmed.2024.1341336. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38751977 Free PMC article.
References
-
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–13. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous